CATALOGO DEI PRODOTTI DELLA RICERCA

TROMBETTA, Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.213
EU - Europa 5.888
AS - Asia 4.045
SA - Sud America 578
AF - Africa 128
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.867
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.065
RU - Federazione Russa 2.227
GB - Regno Unito 1.519
SG - Singapore 1.514
CN - Cina 1.076
IT - Italia 558
BR - Brasile 458
VN - Vietnam 410
HK - Hong Kong 305
DE - Germania 299
SE - Svezia 292
FR - Francia 252
FI - Finlandia 240
IE - Irlanda 203
BD - Bangladesh 178
KR - Corea 165
IN - India 87
CA - Canada 78
JP - Giappone 59
UA - Ucraina 56
MX - Messico 50
ID - Indonesia 45
NL - Olanda 45
AR - Argentina 44
PK - Pakistan 43
PL - Polonia 40
TR - Turchia 35
ZA - Sudafrica 27
AT - Austria 24
NG - Nigeria 24
IQ - Iraq 21
EC - Ecuador 20
BE - Belgio 19
ES - Italia 19
GR - Grecia 16
SA - Arabia Saudita 13
UZ - Uzbekistan 13
BJ - Benin 12
CO - Colombia 12
EG - Egitto 12
PY - Paraguay 12
CL - Cile 11
AU - Australia 10
CZ - Repubblica Ceca 10
DZ - Algeria 10
LT - Lituania 9
VE - Venezuela 9
GH - Ghana 8
JO - Giordania 8
PH - Filippine 8
IR - Iran 7
MA - Marocco 7
RO - Romania 7
TG - Togo 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CR - Costa Rica 6
NO - Norvegia 6
BG - Bulgaria 5
CH - Svizzera 5
KG - Kirghizistan 5
TH - Thailandia 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
DK - Danimarca 4
ET - Etiopia 4
HU - Ungheria 4
IL - Israele 4
KE - Kenya 4
LV - Lettonia 4
MD - Moldavia 4
MY - Malesia 4
NP - Nepal 4
RS - Serbia 4
TN - Tunisia 4
CY - Cipro 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LK - Sri Lanka 3
PE - Perù 3
PT - Portogallo 3
AO - Angola 2
BY - Bielorussia 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
Totale 16.848
Salva come PNG Salva come JPEG
Città #
Southend 1.336
Ashburn 941
Dallas 854
Moscow 812
Singapore 748
Chandler 543
San Jose 536
Jacksonville 323
Hong Kong 297
Woodbridge 235
Verona 234
Beijing 229
Ann Arbor 208
New York 208
Dublin 203
Houston 164
The Dalles 140
Los Angeles 137
Ho Chi Minh City 120
Council Bluffs 107
Helsinki 91
Wilmington 84
Hanoi 80
Lawrence 78
Princeton 78
Jinan 67
Munich 66
Buffalo 58
Santa Clara 56
Nanjing 54
Seoul 52
Tokyo 50
Orem 46
Shenyang 45
Boardman 42
Turku 41
Milan 40
São Paulo 39
Dong Ket 36
Frankfurt am Main 36
Falkenstein 35
Redondo Beach 35
Warsaw 34
London 31
Sindelfingen 29
Tianjin 29
Montreal 27
Hebei 26
Redmond 26
Bologna 25
Columbus 25
Jakarta 24
Zhengzhou 24
Denver 23
Phoenix 22
Rio de Janeiro 22
Amsterdam 21
Nanchang 21
Chennai 20
Lancaster 20
Brussels 19
Haiphong 19
Romola 19
Toronto 19
Hangzhou 18
Abuja 17
Brooklyn 17
Mianwali 17
Nuremberg 17
San Francisco 17
Stockholm 17
Boston 16
Taiyuan 16
Vienna 16
Brasília 15
Changsha 15
Chicago 15
Dearborn 15
Haikou 15
Kent 15
Atlanta 14
Da Nang 14
Johannesburg 14
Shanghai 14
Washington 14
Redwood City 13
Tashkent 13
Cotonou 12
Dhaka 12
Hyderabad 12
Mexico City 12
Paris 12
Rome 12
Taizhou 12
Ankara 11
Dongguan 11
Guangzhou 11
Manchester 11
Poplar 11
Querétaro 11
Totale 10.613
Salva come PNG Salva come JPEG
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 782
Common Variants Associated to Type 2 Diabetes in the Italian Population 492
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 246
Abstracts of 51st EASD Annual Meeting 241
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 236
A low "genetic load" of risk variants for type 2 diabetes is associated to better beta cell function in patients with newly diagnosed type 2 diabetes 227
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 227
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 219
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 219
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 217
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: results from the RAED2 randomized trial 215
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 214
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 214
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 210
Diabetic foot complicated by vertebral osteomyelitis and epidural abscess 210
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 207
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 206
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 204
Confronto delle variazioni acute della glicemia indotte dall'esercizio fisico aerobico o di forza muscolare: studio mediante holter glicemico 204
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 203
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 200
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 200
Assessement of 1th and snd phase of insulin secretion during OGTT and IVGTT 198
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 196
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 195
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 195
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 195
Aerobic and resistence exercise have different short-term effect on glucose levels in type 2 diabetes subject 191
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 191
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 190
Effects of angiotensin II receptor inhibition on insulin-induced endothelial dysfunction in humans. 188
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 186
Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication 185
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 182
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: Results from the RAED2 randomized trial - Note in: Riddell et al., Physical activity and exercise 181
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 179
Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy 178
Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project 178
Accuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes 177
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 177
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 176
Beta-cell function across the spectrum of glucose tolerance in obese youth. 173
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 173
Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report 173
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 172
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 170
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 170
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 168
Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus 163
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 161
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes 158
Estimated peak systolic pulmonary artery pressure in young non-complicated patients with type 1 diabetes 158
Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function 157
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 156
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 155
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 155
Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes 155
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 154
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 153
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 150
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 146
Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study 144
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 144
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 144
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 143
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 139
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 138
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 019 It's beta cell replacement time: 402 - Continuous glucose monitoring and assessment of islet function in autologous islet transplantation after total pancreatectomy for pancreatic neoplasia: preliminary data from the Verona cohort 134
A Randomized Crossover Trial Comparing Glucose Control During Postprandial Moderate Aerobic Activity and High-Intensity Interval Training in Adults With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 132
Evaluating endothelial function of the common carotid artery: An in vivo human model. 132
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young type 1 diabetic individuals 131
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 128
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 124
Continuous subcutaneous insulin infusion in Italy: third national survey. 124
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 123
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 122
Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes 122
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 121
Review article: type 2 diabetes and chronic liver disease in the Verona Diabetes Study 121
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 119
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 116
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children 115
Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes 115
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 114
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 114
Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning 113
Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure 113
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. 112
Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15) 110
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion 110
Methods to assess in vivo insulin sensitivity and insulin secretion 110
Variability of body weight, pulse pressure and glycemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. 109
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 077 Hi Hypo :) I would like to know you better 854 - Detecting hypoglycaemia with glycaemia risk index in adults with type 1 diabetes using continuous glucose monitoring and multiple daily injection therapy: a multicentric real-world study 107
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 106
SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people 105
Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire) 96
Glucose tolerance stages in Cystic Fibrosis are idenfied by a unique pattern of defects of Beta-cell function 92
Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire) 87
Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo—The Maastricht Study 85
Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. 84
Totale 16.949
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.558
article - articoli 37.550
book - libri 0
conference - conferenze 14.588
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 420
Totale 105.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 0 0 82
2021/2022664 82 154 19 55 23 36 13 32 24 18 54 154
2022/20231.427 101 196 120 255 130 323 17 80 139 14 34 18
2023/20241.308 36 61 74 102 100 217 32 308 10 130 164 74
2024/20252.367 96 134 114 449 97 90 152 79 389 137 213 417
2025/20268.030 461 522 774 1.431 1.933 516 622 383 471 450 209 258
Totale 17.120